Keyphrases
Human Liver
100%
Liver Injury
80%
B Cells
80%
Pediatric Liver
80%
Liver Microenvironment
80%
CD4+ T
80%
Cell Population
80%
T Cells
80%
Liver
73%
Liver Disease
40%
Human Leukocyte Antigen
40%
Cellular Compartments
33%
CD4+ TRM
26%
CD4+ T Cells
26%
CD69 Expression
26%
Liver Allograft
26%
Tissue Damage
20%
T Cell Activation
20%
Lymphoma
20%
Anti-inflammatory Cytokines
20%
Viral Hepatitis
20%
Immune Response
20%
Biliary Atresia
20%
Antibody-secreting Cells
20%
Tissue Fibrosis
20%
Transplantation
20%
Persistent Inflammation
20%
Controlled Infection
20%
B Cell Depletion Therapy
20%
Cellular Origin
20%
Alcohol-related
20%
Autoimmune Hepatitis
20%
Primary Sclerosing Cholangitis
20%
Metabolic-associated Fatty Liver Disease (MAFLD)
20%
B Lymphocytes
20%
B Cell Biology
20%
Costimulation
20%
Immunosuppression
20%
End-organ Disease
20%
CD49a
13%
CD8+ TRM
13%
Polyfunctional
13%
Protective Immunity
13%
Tissue-resident
13%
Sentinel
13%
Tissue-resident Memory T Cells
13%
Recirculating
13%
Cytokine Response
13%
Programmed Death-ligand 1 (PD-L1)
13%
Phenotypical
13%
Immunology and Microbiology
Cell Population
80%
T Cell
80%
T-Helper Cell
80%
CD69
40%
Human Leukocyte Antigen
40%
Allograft
40%
CD4
26%
Hepatitis B
13%
Immunity
13%
Interleukin 4
13%
CX3CR1
13%
CXCR6
13%
CXCR3
13%
Cytokine Response
13%
S1PR1
13%
CD49a
13%
Lymph Node
13%
Chemokine Receptor
13%
Memory T Cell
13%
Coculture
13%
Human Tissue
13%
Leukocyte
13%
CD8
13%
Immunosurveillance
13%
Medicine and Dentistry
B Cell
80%
Pediatrics
80%
Liver Injury
80%
Liver Disease
32%
Cytotechnology
16%
Fatty Liver
16%
Cell Compartment
16%
Inflammatory Cytokine
16%
Infection Control
16%
Immune Response
16%
Biliary Atresia
16%
Tissue Injury
16%
Fibrosis
16%
Primary Sclerosing Cholangitis
16%
Hepatitis Virus
16%
Immunosuppressive Treatment
16%
T Cell Activation
16%
Autoimmune Hepatitis
16%
Transplantation
16%
B Lymphocyte
16%
Co-Stimulation
16%
Terminal Illness
16%
Anti-Inflammatory Drug
16%
Antibody Secreting Cell
16%